Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case series
Abstract Background In non-small cell lung cancer, response rates to chemotherapy given after immune checkpoint inhibitors has been reported to be higher compared to response rates to chemotherapy given before immune checkpoint inhibitors. However, this phenomenon has not been reported in patients w...
Main Authors: | Rayan Alsuwaigh, Joycelyn Lee, Gloria Chan, Cheng Ean Chee, Su Pin Choo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-06-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0637-6 |
Similar Items
-
Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies
by: Victor Hugo Fonseca de Jesus, et al.
Published: (2018-10-01) -
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
by: Jerry B. Harvey, et al.
Published: (2020-04-01) -
Gastrointestinal stromal tumor: Role of surgery and immunotherapy
by: Bhatnagar Sushmita
Published: (2010-01-01) -
Immunotherapy Strategies for Gastrointestinal Stromal Tumor
by: Junaid Arshad, et al.
Published: (2021-07-01) -
Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
by: Ding-Kang Wang, et al.
Published: (2021-08-01)